Role of Statins and Resveratrol in PCOS Management
- 14 April 2022
- book chapter
- Published by Springer Nature
- p. 255-277
Abstract
No abstract availableKeywords
This publication has 126 references indexed in Scilit:
- Resveratrol Is Not as Effective as Physical Exercise for Improving Reproductive and Metabolic Functions in Rats with Dihydrotestosterone-Induced Polycystic Ovary SyndromeEvidence-Based Complementary and Alternative Medicine, 2013
- Medical management of metabolic dysfunction in PCOSSteroids, 2012
- p38α Mediates Cell Survival in Response to Oxidative Stress via Induction of Antioxidant GenesJournal of Biological Chemistry, 2012
- Proatherogenic Abnormalities of Lipid Metabolism in SirT1 Transgenic Mice Are Mediated through Creb DeacetylationCell Metabolism, 2011
- Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysisHuman Reproduction Update, 2011
- Statins in the Treatment of Polycystic Ovary SyndromeSeminars in Reproductive Medicine, 2008
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic ratJournal of Molecular and Cellular Cardiology, 2007
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- The Molecular Basis for Oxidative Stress-Induced Insulin ResistanceAntioxidants & Redox Signaling, 2005